| CYSB2400279 | 人纤维蛋白原 | Human fibrinogen | Lyophilized | Biological Products | Supplementary Application | 2024-10-23 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSB2400122 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(2.4) | Supplementary Application | 2024-10-13 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL2400412 | 静注人免疫球蛋白（pH4) | human immunoglobulin(PH4) | Injection | Biological Products(3.2) | New Drug Application | 2024-06-26 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2400160 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-06-21 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2400114 | 静注人免疫球蛋白（pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2024-05-15 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2400087 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | Supplementary Application | 2024-04-09 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL2400072 | 人凝血因子IX | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(3.4) | New Drug Application | 2024-01-31 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL2300639 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(2.4) | New Drug Application | 2023-09-21 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL2300638 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(2.4) | New Drug Application | 2023-09-21 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2300152 | 破伤风人免疫球蛋白 | human tetanus immunoglobulin | Injection | Biological Products | Supplementary Application | 2023-08-19 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2300113 | 人纤维蛋白原 | Human fibrinogen | Lyophilized | Biological Products | Supplementary Application | 2023-06-13 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2200109 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2022-04-29 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2200078 | 人纤维蛋白原 | Human fibrinogen | Lyophilized | Biological Products | Supplementary Application | 2022-03-16 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSS2200014 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2022-02-18 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2200014 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-01-14 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2101280 | 破伤风人免疫球蛋白 | human tetanus immunoglobulin | Injection | Biological Products | Supplementary Application | 2021-12-22 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2101143 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2021-08-10 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2101142 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2021-08-10 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2101145 | 人免疫球蛋白 | human immunoglobulin | Injection | Biological Products | Supplementary Application | 2021-08-10 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2101146 | 破伤风人免疫球蛋白 | human tetanus immunoglobulin | Injection | Biological Products | Supplementary Application | 2021-08-10 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
